Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Véronique Leblond1, Agnès Bellanger2

  • 1Hématologie clinique.

La Revue Du Praticien
|December 5, 2018
PubMed
Summary

New ambulatory care models are needed for chronic lymphocytic leukemia (CLL) patients, especially older adults with multiple conditions. This approach focuses on multidisciplinary, patient-centered home care to improve treatment and manage side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO group.

EClinicalMedicine·2026
Same author

Late toxicity and long-term efficacy of first-line bendamustine and rituximab combination in patients with Waldenström macroglobulinemia.

Leukemia·2025
Same author

Waldenström's macroglobulinemia: The LYSA pragmatic guidelines.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Phenotypic Profile of Waldenström Macroglobulinaemia B-Cells: Establishment of a Diagnosis Scoring System and Clinico-Biological Correlations.

Journal of cellular and molecular medicine·2025
Same author

Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia.

Blood advances·2024
Same author

Expert Opinion on Managing Adverse Reactions Associated With Acalabrutinib Therapy: A Delphi Consensus From France.

Clinical lymphoma, myeloma & leukemia·2024

Area of Science:

  • Oncology
  • Hematology
  • Geriatric Medicine

Context:

  • Hematologic malignancies, including chronic lymphocytic leukemia (CLL), have seen significant treatment advancements.
  • Older patients with CLL often present with multimorbidity and polypharmacy, complicating management.
  • The traditional hospital-centric model is shifting towards more integrated care approaches.

Purpose:

  • To introduce a new paradigm for ambulatory care management in chronic lymphocytic leukemia (CLL).
  • To address the complexities of treating elderly CLL patients with multiple comorbidities and medications.
  • To propose a patient-centered home care model coordinated by hospitals.

Summary:

  • Emerging targeted oral therapies for CLL necessitate a shift in care delivery.
Keywords:
Leucémie lymphoïde chroniquePrise en charge de la leucémie lymphoïde chronique en ambulatoire : un nouveau concept

Related Experiment Videos

  • A multidisciplinary approach is crucial for managing adverse reactions and drug-drug interactions in elderly patients.
  • Key objectives include optimizing medication use, coordinating care, and enhancing patient and professional education.

    • Impact:

    • Facilitates a transition from hospital-centered to patient-centered home care for CLL management.
    • Aims to prevent treatment discontinuities and improve the overall quality of care for CLL patients.
    • Requires collaboration between healthcare establishments, professionals, and patient organizations for successful implementation.